http://www.acc.org/Feed?clinicalTopicID=1049cd29-7519-4ec9-9b2f-a012cd071676 Clinical Topic Feed: Advanced Lipid Testing en /Latest-in-Cardiology/Journal-Scans/2025/12/09/16/51/ODYSSEY-OUTCOMES Although elevated oxidized phospholipids on apolipoprotein B-100 (OxPL-apoB) levels predicted major adverse cardiovascular events (MACE) in patients with a recent acute coronary syndrome (ACS) receiving optimized statin treatment, alirocumab significantly attenuated the risk. 1765375740000 Articles and Stories /Latest-in-Cardiology/Articles/2025/12/01/01/Feature-Lipoprotein-a Lipoprotein(a) [Lp(a)] has evolved from a biochemical curiosity to a central player in cardiovascular risk assessment, with elevated levels affecting approximately 1.5 billion people worldwide as an independent and causal risk factor for atherosclerotic cardiovascular disease (ASCVD) and calcific aortic valve disease. 1764594900000 Articles and Stories /Latest-in-Cardiology/Articles/2025/08/01/01/JACC-in-a-Flash Featured topics and Editors' Picks from all of ACC's JACC Journals. 1754050200000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2025/06/11/14/30/Predicting-Long-Term-Risk-of-CVD Most adults in the U.S. have elevated long-term risks of cardiovascular disease based on findings using the PREVENT risk equations, published June 9 in JACC. 1749668700000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2025/05/28/13/17/New-Research-Adds-to-Growing-Evidence New original research – part of a special JACC focus issue on lipids – adds to the growing body of evidence surrounding lipoprotein(a) (Lp[a]) and its contribution as an independent causal risk factor for cardiovascular disease and aortic stenosis. 1748464020000 Articles and Stories /Latest-in-Cardiology/Articles/2025/05/01/01/Journal-Wrap The hottest research from various peer-reviewed journals – handpicked weekly by the ACC. 1746101460000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2025/04/23/13/28/Lp-a-and-CV-Risk A significant burden of elevated lipoprotein(a) [Lp(a)] was observed in a large health check-up population in China and elevated Lp(a) was associated with site-specific subclinical atherosclerosis and a stronger association with severe extent and multisite involvement... 1745432760000 Articles and Stories /Latest-in-Cardiology/Journal-Scans/2025/04/10/13/42/Can-a-One-Time-Universal-Measurement-of-Three-Risk-Factors An early one-time simultaneous measurement of LDL-C, high-sensitivity C-reactive protein (hsCRP) and lipoprotein(a) (Lp[a]) can independently predict long-term cardiovascular risk, according to a large prospective cohort study ... 1744301640000 Articles and Stories /Latest-in-Cardiology/Clinical-Trials/2025/03/27/18/03/alpaca The goal of the ALPACA phase 2 trial was to assess the safety of lepodisiran in patients with higher lipoprotein(a) concentrations, determine the magnitude and duration of the reduction in lipoprotein(a) concentrations, and help inform the dose and dosing interval for a long-term phase 3 trial assessing cardiovascular outcomes, which is currently under way. 1743307200000 Articles and Stories /Latest-in-Cardiology/Articles/2025/01/21/13/51/accel-lite-21jan2025 In this interview, Drs. Laxmi Mehta and Michael Shapiro discuss the role and importance of advanced lipid testing. 1737482820000 Articles and Stories